Page last updated: 2024-08-21

fluorobenzenes and Left Ventricular Hypertrophy

fluorobenzenes has been researched along with Left Ventricular Hypertrophy in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK1
Li, WH; Ma, YX; Xie, Q1
Chang, HJ; Chang, SA; Kim, DH; Kim, HK; Kim, YJ; Lee, HW; Oh, BH; Park, YB; Sohn, DW1
Ganguli, A1
Andresen, BT; Dellsperger, KC; DeMarco, VG; Ferrario, CM; Gutweiler, AA; Habibi, J; Johnson, MS; Ma, L; Schneider, RI; Sowers, JR; Whaley-Connell, AT1
Crijns, HJ; De Leeuw, PW; de Vos, C; Folkeringa, RJ; Habets, J; Pinto, YM; Prins, MH; Tieleman, RG; Van Dieijen-Visser, M1
Dong, XM; Liao, Y; Liu, L; Qu, XF; Yin, DC1

Trials

2 trial(s) available for fluorobenzenes and Left Ventricular Hypertrophy

ArticleYear
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
    JACC. Cardiovascular imaging, 2013, Volume: 6, Issue:2

    Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling

2013
No effect of rosuvastatin on left ventricular hypertrophy in patients with hypertension: a prospective randomised open-label study with blinded endpoint assessment.
    International journal of cardiology, 2010, Nov-05, Volume: 145, Issue:1

    Topics: Aged; Cholesterol, LDL; Endpoint Determination; Female; Fluorobenzenes; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2010

Other Studies

5 other study(ies) available for fluorobenzenes and Left Ventricular Hypertrophy

ArticleYear
Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
    Die Pharmazie, 2013, Volume: 68, Issue:5

    Topics: Animals; Body Weight; Cardiomyopathies; Collagen; Creatine Kinase; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Fluorobenzenes; Glycated Hemoglobin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Natriuretic Peptide, Brain; Pyrimidines; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Transforming Growth Factor beta1

2013
Effect of rosuvastatin on cardiac remodeling, function, and progression to heart failure in hypertensive heart with established left ventricular hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2009, Volume: 54, Issue:3

    Topics: Animals; Blood Pressure; Collagen; Disease Progression; Fibrosis; Fluorobenzenes; Heart; Heart Failure; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Myocardium; Organ Size; Pyrimidines; Random Allocation; Rats; Rats, Inbred Dahl; Rosuvastatin Calcium; Sulfonamides

2009
Rosuvastatin in patients undergoing hemodialysis.
    The New England journal of medicine, 2009, Jul-02, Volume: 361, Issue:1

    Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Phosphorus; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides

2009
Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat.
    American journal of physiology. Heart and circulatory physiology, 2009, Volume: 297, Issue:3

    Topics: Angiotensinogen; Animals; Fluorobenzenes; Heart Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Hypertrophy, Right Ventricular; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Peptidyl-Dipeptidase A; Pulmonary Artery; Pyrimidines; rac1 GTP-Binding Protein; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Rosuvastatin Calcium; Sulfonamides; Ventricular Function, Left; Ventricular Function, Right

2009
[Sympathetic nerve in rat with pressure overload left ventricular hypertrophy].
    Zhonghua yi xue za zhi, 2009, Sep-15, Volume: 89, Issue:34

    Topics: Acyl Coenzyme A; Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Male; Myocardium; Pressure; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sulfonamides; Sympathetic Nervous System

2009